Forced selling going into overdrive. Why liquidate this one? Guess waiting a couple years for profits doesn't work during panics.
Lots of pain today, Friday I can't think about. On the verge of puking.
Took new management a while to get out from under the nearly bankrupting money losing contracts. $1+ could be just the beginning for those willing to stay the course. Rite Aid is a good example of how profitable turnarounds can be. Got out way too early on that one.
I know Wall Street runs the show and to never bet against the boyz. It just looks like GASL has to eventually reflect natural gas???
Henry Hub Natural Gas Futures Quotes for future months as weather turns cooler are all sitting at around $3. The Coal to Gas thing is real.
This Wall Street GASL looks like a legal way for Wall Street to put moar money in Wall Street pockets. And everyone know gas storage will see a nice build Thursday.
How do you guys play this one. Does Wall Street eventually square up with Nymex and futures. (Also see pollution in China and how badly they need to close coal powered plants)
Coal use is dropping fast around the world. Natural gas demand to replace coal in demand to replace coal sources for power plants. Limited downside in the dog days of summer and in the future as more coal power plants are put out of commission.
Workers request AC for warehouse. With time employee passes out from heat exhaustion and goes to hospital (Insert BEZO's creepy laugh). AMZN puts in AC in warehouse.
More Bezo bizzaro laugh. Bezo denies culture he created to push volume out the door at any cost. I'll think about that when I consider buying from Amazon, HaHaHa.
Note that last July TechPrecision mentioned the concern of capacity to fulfill Mevion obligations and satisfy existing customers.
I'm guessing the run on this stock could be HUGE as Mevion may be accelerating.
LITTLETON, MASS., August 4, 2015 – Mevion Medical Systems, the leading provider of advanced proton therapy systems, announced today that it has entered into an investment agreement where up to $200 million will be invested in Mevion to accelerate its worldwide expansion.
After years of mismanagement and signing contracts that were Huge losses looks like TechPrecision's last CC of shut and promise nothing is understandable. Turnaround is a show me game.
From July '14 CC
* $8 million in the fiscal year ended March 31, 2013 (Mevion is in an impressive growth trajectory with 5 sites now under construction)
* It’s a very efficient use of our capacity. (nice margins?)
* What we really need to see is all five of those next units going in earnest at a good pace that really fills Ranor’s capacity. And if we get up into the high eight figures meaning that the loaded mid-teens, we then really have to think about balancing our capacity at Ranor to host that type of volume from Mevion.
* So again we work with them over a two to five year planning horizon which is the life span of that exclusive supply agreement we are in with them. And we try to make sure we can have the capacity available with our other customers and with the additional load on the Ranor facility.
If Wall Street sees too many billions hedged on the short side of oil WS will walk her up and pocket those hedges. Then down we go down and settle.
If China slows, the BRICS, Germany & Commodity Countries slow harder. Oil demand with it. Russia is a basket case regardless.
Spiral to a bathtub recovery for oil. A couple years of weak prices.
The rest of the staff seemed up beat. He was like a dog holding his favorite bone. Nobody was getting anything from him. With Mevion's future coming to fruition I have a funny feeling it was the Elephant size secret in the room.
Go back and look up some of the potential TPCS saw in an expanding Mevion.
I think I will have a lot more patience for this one. Again, how soon will Seeking Alpha article put out a bullish article.
Aveo has invested so much in bringing along their RCC drug and with so much positive feed back on "one more trial" Novartis must be a little curious about taking over the whole company. Maybe Aveo's feed back has been so encouraging they are going for a much bigger payout.
Maybe Novartis will be happy just buying the European rights and helping to funding the tab for "one more phase III trial"
No more Hand and Foot side effect gives this a step up with the leaders in RCC. Novartis knows it has a drug for RCC.
GLTA, buying dips at this point and building a position. Anyone want to guess if it goes much lower in the face of a very spooked overall market?
The huge effort at not wanting to give any news on the forward outlook was laughable. Something too hide? Feeling better about that as I see the developments of turning the corner in profitability and Mevion getting the $200M JV capitol. Until this CC Mevion has been left out of CC.
Buy the dips.
Novartis would be very helpful in navigating European approval process for Tevozanib. Hope details are coming.
Another strong up day. Merivon has a $200 M cash infusion. Wild speculation as this is the kind of business that China may purchase and move over to it's shores?
The CC was extremely odd and the subject of future trends was soooooo taboo. Something is up and it is coming just as TechPrecision is turning the corner.
Would they be interesed in codeveloping Tevozanib? FDA has reconsidered and is encouraging a third trial for approval. Early European review has been very encouraging, think Novartis could help in getting this approval?
See Tevozanib the improved side effect and potency equal to competitors. Wonder which drug Novartis and Aveo really want to come to an agreement on?
GLTA, think it's time to buy dips. Don't think we will see the $13 target but there are plenty of profitable points below $13.